Results 271 to 280 of about 185,884 (310)
Some of the next articles are maybe not open access.
Atherosclerotic cardiovascular disease in rheumatoid arthritis
Current Rheumatology Reports, 2003The past 3 years have seen a remarkable growth in the interest of cardiovascular disease in rheumatoid arthritis. There have been studies published documenting an increased incidence and prevalence of cardiovascular conditions in patients with rheumatoid arthritis compared with individuals without rheumatoid arthritis.
Inmaculada, del Rincón +1 more
openaire +2 more sources
Chelation therapy for atherosclerotic cardiovascular disease
Cochrane Database of Systematic Reviews, 2002Chelation therapy is being promoted and practiced all over the world as a form of alternative medicine in the treatment of atherosclerotic cardiovascular disease. It has been recommended as a safe, relatively inexpensive and non-surgical method of restoring blood flow in atherosclerotic vessels.
M V, Villarruz, A, Dans, F, Tan
openaire +2 more sources
Haematometabolism rewiring in atherosclerotic cardiovascular disease
Nature Reviews CardiologyAtherosclerotic cardiovascular diseases are the most frequent cause of death worldwide. The clinical complications of atherosclerosis are closely linked to the haematopoietic and immune systems, which maintain homeostatic functions and vital processes in the body.
Laurent Yvan-Charvet +2 more
openaire +2 more sources
Remnant lipoproteins and atherosclerotic cardiovascular disease
Clinica Chimica Acta, 2019Lipoproteins are one of the major risk factors for atherosclerotic cardiovascular disease (ASCVD), among which, low-density lipoprotein (LDL) particles have been definitively shown to be causally associated with the development of ASCVD. Additionally, the concept of remnant lipoproteins has emerged as lipoprotein metabolism has been fully investigated.
Hayato Tada +4 more
openaire +2 more sources
Lasers: Applications in Cardiovascular Atherosclerotic Disease
Critical Care Nursing Clinics of North America, 1989Laser angioplasty is a new, yet experimental intervention in the vascular setting. This technique forces artificially stimulated electrons to generate light energy. This energy can be used to achieve tissue abatement by a variety of mechanisms. Reducing resultant complications from this technique is the goal of current laser research.
openaire +2 more sources
Prevention of Atherosclerotic Cardiovascular Disease in Childhood
Current Cardiology Reports, 2020Atherosclerotic-CVD processes begin early in life and are influenced over the life course by interaction of genetic and potential modifiable risk factors, behaviors, and environmental exposures. The purpose of this review is to highlight importance of primordial and primary prevention beginning early in the life course.Evidence-based guidelines and ...
openaire +2 more sources
Cystatin C in atherosclerotic cardiovascular disease
Clinica Chimica ActaAtherosclerotic cardiovascular disease (ASCVD) remains the leading cause of global mortality. While traditional risk factors are central to prevention, there is a pressing need for novel biomarkers to improve risk stratification and identify individuals with a high burden of disease.
Siarhei A, Dabravolski +5 more
openaire +2 more sources
Current pharmacotherapies for atherosclerotic cardiovascular diseases
Archives of Pharmacal Research, 2019Despite the introduction of statins for lowering LDL-C level, atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of death and morbidity worldwide. Combination therapies with statin and other lipid-lowering drugs, including ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, have unlocked additive benefits
Jong-Gil, Park, Goo Taeg, Oh
openaire +2 more sources
Association of epistaxis with atherosclerotic cardiovascular disease
The Laryngoscope, 2018Objectives/HypothesisTo investigate the association between epistaxis and atherosclerotic cardiovascular disease.Study DesignCase‐control cohort study.MethodsThis study included patients from the tertiary‐care ear, nose, and throat department at the University Hospital of Zurich between December 1, 2016 and June 1, 2017.
Kunz, Seraina M +2 more
openaire +2 more sources
Effect of niacin on atherosclerotic cardiovascular disease
The American Journal of Cardiology, 1998Niacin has been studied in 6 major clinical trials with cardiovascular endpoints. The Coronary Drug Project (CDP) was the largest of these trials and the only one to use niacin monotherapy affecting cardiovascular outcomes: recurrent myocardial infarction and cerebrovascular events were significantly decreased.
openaire +2 more sources